Katja Sockel

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 535 citations · Full text

Transplantation, Stem Cell Transplantation, Transplantation Medicine +9

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel et al. · The Lancet Oncology · 2018 · 341 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +10

<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

Franziska Taube, Julia Annabell Georgi, Michael Krämer et al. · Blood · 2021 · 159 citations · Full text

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

Jan‐Niklas Eckardt, Jan Moritz Middeke, Sebastian Riechert et al. · Leukemia · 2021 · 106 citations · Full text

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

Felix von Dalowski, Michael Krämer, Martin Wermke et al. · Stem Cells · 2015 · 93 citations · Full text